Although OS is a genetically complex cancer that lacks a defining chromosomal alteration or gene mutation, the pathogenesis of OS is increasingly linked to the inactivation of TP53, often potentiated by the loss of function of RB1 [6, 27, 28]. The gene discussed is RB1; the disease is cancer.